Valuation: AstraZeneca PLC

Market Cap 262B 230B 213B 196B 370B 25,020B 378B 2,542B 995B 12,269B 983B 961B 42,502B P/E 2026 *
21.1x
P/E 2027 * 18.5x
Enterprise Value 281B 247B 229B 210B 397B 26,856B 406B 2,728B 1,068B 13,170B 1,055B 1,031B 45,620B EV / Sales 2026 *
4.44x
EV / Sales 2027 * 4.1x
Free-Float
96.63%
Yield 2026 *
1.98%
Yield 2027 * 2.09%

Last Transcript: AstraZeneca PLC

1 day-1.75%
1 week-12.77%
Current month-10.57%
1 month-6.33%
3 months-17.20%
6 months-10.69%
Current year-8.56%
1 week 12,388
Extreme 12388
14,478
1 month 11,484
Extreme 11484
15,126
Current year 11,232
Extreme 11232
15,732
1 year 10,178
Extreme 10178
15,732
3 years 9,461
Extreme 9461
15,732
5 years 8,029
Extreme 8029
15,732
10 years 3,996
Extreme 3996
15,732
Manager TitleAgeSince
Chief Executive Officer 66 2012-09-30
Director of Finance/CFO 52 2021-07-31
Compliance Officer - 2022-12-31
Director TitleAgeSince
Director/Board Member 70 1999-04-05
Director/Board Member 66 2012-09-30
Director/Board Member 65 2017-04-26
Date Insider Type Main position Quantity % Market Cap.
Jul. 05Free

See Remarks

2 0.0000%
Jun. 07Free

See Remarks

1 0.0000%
May. 19Sell

See Remarks

-11,893 0.0008%
Change 5-day change 1-year change 3-year change Capi.($)
-1.75%-12.77%+20.67%+23.05% 267B
-0.56%-2.64%+49.04%+168.24% 1,060B
+0.31%-2.00%+64.29%+63.06% 619B
-0.03%-5.01%+28.86%+83.73% 438B
-1.75%-2.91%+28.78%+24.35% 333B
+0.24%-2.61%+29.46%+46.50% 282B
+0.67%-0.76%-26.10%-37.25% 218B
-0.81%-3.66%+22.07%+59.72% 196B
+1.21%+0.10%+19.85%+72.03% 161B
+1.28%+0.66%-4.56%-31.98% 138B
Average -0.01%-3.06%+23.24%+47.14% 371.17B
Weighted average by Cap. +0.03%-3.00%+34.76%+78.72%

Financials

2026 *2027 *
Net sales 63.22B 55.54B 51.46B 47.37B 89.46B 6,045B 91.39B 614B 240B 2,964B 237B 232B 10,268B 66.8B 58.69B 54.37B 50.05B 94.53B 6,387B 96.57B 649B 254B 3,132B 251B 245B 10,850B
Net income 12.43B 10.92B 10.12B 9.32B 17.59B 1,189B 17.97B 121B 47.25B 583B 46.68B 45.66B 2,019B 13.94B 12.25B 11.34B 10.44B 19.72B 1,333B 20.15B 135B 52.97B 653B 52.33B 51.18B 2,264B
Net Debt 19.2B 16.87B 15.63B 14.38B 27.17B 1,836B 27.75B 186B 72.97B 900B 72.08B 70.5B 3,118B 11.95B 10.5B 9.72B 8.95B 16.9B 1,142B 17.27B 116B 45.4B 560B 44.85B 43.87B 1,940B
Logo AstraZeneca PLC
AstraZeneca PLC is one of the world's leading pharmaceutical groups. Net sales break down by source of income as follows: - product sales (99.8%). Net sales break down by treatment area between oncology (42.6%), cardiovascular, renal and metabolic diseases (23%), respiratory and autoimmune diseases (14.7%), and other (19.7%; inflammatory diseases, neurological diseases, gastrointestinal and infectious diseases); - collaboration revenue (0.2). Net sales are distributed geographically as follows: the United Kingdom (7.4%), Europe (22.9%), the United States (40.8%), Americas (6.1%) and Africa/Asia/Australia (22.8%).
Employees
96,100
Date Price Change Volume
26-07-13 GBX 12,610.00 -1.75% 2,741,916
26-07-10 GBX 12,834.00 -3.89% 3,355,019
26-07-09 GBX 13,354.00 -6.22% 7,624,478
26-07-08 GBX 14,240.00 -0.86% 1,480,149
26-07-07 GBX 14,364.00 +1.87% 1,528,247
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
24
Last Close Price
172.23USD
Average target price
212.94USD
Spread / Average Target
+23.64%

Quarterly revenue - Rate of surprise